Trinity College Dublin

Skip to main content.

Top Level TCD Links

About Trinity Biomedical Sciences Institute

The Trinity Biomedical Sciences Institute (TBSI) is an environment where innovative and interdisciplinary approaches are leading to scientific discoveries of biomedical importance, ultimately giving rise to better patient care. The mechanistic basis for a whole range of diseases is under investigation, including infectious and inflammatory diseases such as arthritis and Type 2 diabetes, neurological diseases such as motor neuron disease and multiple sclerosis, and different forms of cancer.

Our focus is on outstanding discovery, since there remains a major unmet medical need for the treatment of these diseases and our understanding of the molecular basis of many diseases remains limited.

TBSI also houses all of our preclinical training in our medical degree. We aim to foster a spirit of interaction and exploration on the frontiers of biomedical research, such that truly ground-breaking discoveries can be made. We have established 3 centres in TBSI – Centre for Cancer Drug Discovery (C2D2), the Centre of Medical Device Technologies (CMDT) and Centre for Translational Medicine . We are also supporting spin out companies such as Trimod Therapeutics, and are working with several pharmaceutical and medical device companies.

The participating Schools are the School of Biochemistry and Immunology , School of Chemistry , School of Medicine , A School of Engineering (Bioengineering) , and School of Pharmacy and Pharmaceutical Sciences and they carry out research programmes in a state-of-the-art facility designed to maximise interaction and facilitate co-operation.

We are establishing core technologies of the highest standard, including in NMR and transgenics. TBSI will allow our researchers to continue to perform at the highest level and copper-fasten Trinity's place as a leading international scientific university.



Image of Kingston Mills"
Kingston Mills

Prof Kingston Mills

Academic Director

Back to top

Last updated 20 May 2019 by Caroline Levis (Email).